TransMedics (TMDX) Return on Capital Employed (2019 - 2026)

TransMedics' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 8.14% for Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 128.0% year-over-year to 8.14% in Q1 2026; TTM through Mar 2026 was 8.14%, a 128.0% increase from a year earlier, with the FY2025 full-year figure at 12.82%, up 743.0% from the prior year.
• Return on Capital Employed fell to 8.14% in Q1 2026 per TMDX's latest filing, from 11.83% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 11.83% in Q4 2025 and bottomed at 43.07% in Q2 2022.
• The 5-year median for Return on Capital Employed is 2.14% (2024), against an average of 4.89%.
• Across the five-year window, Return on Capital Employed slumped 2208 bps in 2022 and surged 3972 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 12.46% in 2022, then jumped by 64 bps to 4.47% in 2023, then jumped by 214 bps to 5.1% in 2024, then soared by 132 bps to 11.83% in 2025, then plunged by 31 bps to 8.14% in 2026.
• Per Business Quant, the three latest TMDX Return on Capital Employed figures stand at 8.14% (Q1 2026), 11.83% (Q4 2025), and 11.44% (Q3 2025).